What is Rds?
RDS is an innovative company specializing in remote patient monitoring, developing, manufacturing, and marketing MultiSense®, a next-generation remote medical monitoring solution. Headquartered in Strasbourg, France, within the IHU, RDS leverages an international team and collaborates on major research projects such as DARE and 5G-OR. The company's focus on advanced medical monitoring technology positions it at the forefront of digital health innovation.
How much funding has Rds raised?
Rds has raised a total of $30.2M across 2 funding rounds:
Angel/Seed
$13.6M
Series A
$16.6M
Angel/Seed (2023): $13.6M with participation from Capital Grand Est
Series A (2025): $16.6M led by BPI France
Key Investors in Rds
BPI France
BPI France is an emerging entity focused on digital transformation and innovation, aiming to assist businesses in enhancing their digital capabilities. Further details are anticipated upon their official website launch.
Capital Grand Est
Capital Grand Est is a regional private equity management company based in Schiltigheim, France, that manages investment and equity funds.
What's next for Rds?
The recent major strategic investment signals a new phase of expansion for Rds. This capital will likely fuel further development of its MultiSense® platform, enhance manufacturing capabilities, and broaden market reach. The company's strategic positioning within the IHU and its collaborations on cutting-edge research projects suggest a strong emphasis on technological advancement and integration into future healthcare ecosystems. Future growth will likely involve scaling operations and solidifying its presence in the competitive remote patient monitoring sector.
See full Rds company page
